Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if ibudilast is effective in reverting patients with medication overuse headache suffering chronic daily headache back to their original episodic headache pattern.


Clinical Trial Description

It has been established that excessive intake of medications used to treat primary headaches, particularly those containing opioids, can induce a form of secondary headache, known as medication overuse headache (MOH). Despite the significant clinical impact of this condition the mechanisms behind MOH remain poorly understood, guidelines for treatment are lacking, and relapse is common.

Recently, it has been recognised that repeated opioid exposure can facilitate pain by activating glia, the immunocompetent cells of the central nervous system, resulting in opioid-induced hyperalgesia (OIH).

The investigators hypothesise that MOH represents a form of OIH in this susceptible patient group - repeated activation of nociceptive pathways by frequent headaches interacts with the opioid induced pro-inflammatory actions of activated glia to produce chronic daily headache (CDH).

This double-blind, randomised, placebo controlled pilot study will investigate the use of ibudilast, a know attenuator of glial activation, in the treatment of medication overuse headache. ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01317992
Study type Interventional
Source University of Adelaide
Contact Paul Rolan, MD FRACP
Phone +61 8 8303 4102
Email paul.rolan@adelaide.edu.au
Status Recruiting
Phase Phase 1/Phase 2
Start date April 2011
Completion date August 2013

See also
  Status Clinical Trial Phase
Completed NCT05720819 - Biofeedback-VR for Treatment of Chronic Migraine N/A
Terminated NCT02583425 - Pilot Study of DFN-11 Injection in Medication Overuse Headache Phase 2
Recruiting NCT03655184 - An Observation Study on Neuropsychology and Serum Melatonin Level in Patients With Medication Overuse Headache
Active, not recruiting NCT02993289 - Is Detoxification Needed in Medication-overuse Headache? N/A
Active, not recruiting NCT05608642 - Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment N/A
Recruiting NCT03671681 - Mindfulness Therapy for Chronic Migraine N/A
Completed NCT01078012 - Short Intervention for Medication Overuse Headache (MOH) - Pilot N/A
Completed NCT03767062 - Peripheral Nerve Block and Topiramate in the Treatment of Medication Overuse Headaches N/A
Recruiting NCT01754571 - CBT in Patients With Medication Overuse Headache Phase 0
Completed NCT02435056 - Medication Overuse Headache (MOH) and an Innovative Approach N/A
Recruiting NCT05452239 - A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache Phase 4
Completed NCT01044251 - Frovatriptan as a Transitional Therapy in Medication Overuse Headache Phase 2
Completed NCT00918671 - Medication-overuse Headache: 4 Years Follow up
Completed NCT04336267 - Anodal tDCS in Chronic Migraine With Medication Overuse N/A
Enrolling by invitation NCT01752439 - Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache N/A
Completed NCT00833209 - Orbitofrontal Cortex (OFC) Influence on Addictive Medication Overuse Headache (MOH) Deriving From Migraine N/A
Completed NCT04772742 - Eptinezumab in Adults With Migraine and Medication Overuse Headache Phase 3
Completed NCT04228809 - tDCS in Chronic Migraine With Medication Overuse (Edisom) N/A
Not yet recruiting NCT05334927 - China HeadAche DIsorders RegiStry
Completed NCT04090333 - Endocrinological Profile in Patients With Medication-overuse Headache Before and After Withdrawal Therapy